Ori Grossberger, Adi Sherban, Irina Amitai, Ilana Hellmann, Boaz Nachmias, Ofir Wolach, Yakir Moshe. "Disease status at initiation of blinatumomab and depth of response after cycle 1 are associated with survival in Philadelphia chromosome positive B cell acute lymphoblastic leukemia patients treated with blinatumomab and tyrosine kinase inhibitors." Blood (2025). https://doi.org/10.1182/blood-2025-3321